General Information
Version
8.3
Revision date
2026-03-19
Product name
ApopTag Peroxidase In Situ Oligo Ligation Apoptosis Detection Kit
REACH No
This
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H319, H334, H335, H341, H350, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
H319
Causes serious eye irritation
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335
May cause respiratory irritation
H341
Suspected of causing genetic defects
H350
May cause cancer
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Labelling according Regulation (EC) No 1272/2008 as amended by GB-CLP Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H341 Suspected of causing genetic defects. H350 May cause cancer. H412 Harmful to aquatic life with long lasting effects. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H341 Suspected of causing genetic defects. H350 May cause cancer. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing mist or vapours. P273 Avoid release to the environment. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing mist or vapours. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended by GB-CLP Regulation, UK SI 2019/720, and UK SI 2020/1567 Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Respiratory sensitisation, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Germ cell mutagenicity, H341: Suspected of causing genetic (Category 2) defects. Carcinogenicity, (Category 1B) H350: May cause cancer. Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3), Respiratory system Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.